Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs directed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where therapy choices remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Check out Our Pipeline https://financefeeds.com/usdjpy-technical-analysis-report-12-march-2025/